SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-21-079854
Filing Date
2021-03-12
Accepted
2021-03-12 17:16:29
Documents
8
Group Members
HORIZON THERAPEUTICS USA, INC.TEIRIPIC MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d127825dsctota.htm SC TO-T/A 47544
2 EX-99.(D)(6) d127825dex99d6.htm EX-99.(D)(6) 40847
3 EX-99.(D)(7) d127825dex99d7.htm EX-99.(D)(7) 40888
4 EX-99.(D)(8) d127825dex99d8.htm EX-99.(D)(8) 41085
5 EX-99.(D)(9) d127825dex99d9.htm EX-99.(D)(9) 20022
6 GRAPHIC g127825g0312080300929.jpg GRAPHIC 1951
7 GRAPHIC g127825g0312105227130.jpg GRAPHIC 1992
8 GRAPHIC g154787g0312105227130.jpg GRAPHIC 1992
  Complete submission text file 0001193125-21-079854.txt   200905
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filed by) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Subject) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91167 | Film No.: 21738517
SIC: 2834 Pharmaceutical Preparations